Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER

No-Receipt date 2022-02751 - 04/08/2022
No-Filing date 20220401605 - 04/08/2022
No-Granting date 3110897 - 08/09/2022
No-EPO application date 18829742.8 - 05/12/2018
No-EPO granting date 3720879 - 11/05/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 9/2022 - 10/10/2022
Expiration date 06/12/2038
Kind of title Validation of European Patent
Legal status VALID
Priorities US201762594755 P05/12/2017/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07K 16/28
C07K 16/26
A61K 39/395

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1429381 PROGASTRINE ET CANCERS S.A R.L. 11, COTE D`EICH1450 LUXEMBOURG LUXENBOURG

Inventors
CodeFirstnameSurname
3687985 PRIEUR, ALEXANDRE

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 7 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015